Company / Book Value per Share
Barinthus Biotherapeutics plc. Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.844
FY2025
5-year range
-$4.637 / $6.531
FY2021-FY2025
Trend
-45.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 3 consecutive years, from $6.531 in FY2022 to $1.844 in FY2025.
Based on SEC 10-K filings.
$1.844 in FY2025 with a 3-year CAGR of -34.4%.
Declined from $4.957 to $1.844 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -34.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Barinthus Biotherapeutics plc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -34.4%, indicating a declining trend.
- In FY2025, book value per share decreased 45.2% year-over-year.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.844 | -45.2% |
| FY2024 | $3.365 | -32.1% |
| FY2023 | $4.957 | -24.1% |
| FY2022 | $6.531 | +240.9% |
| FY2021 | -$4.637 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026